\n\n
Webinar Overvi
ew
\n
In this webinar\, Oksana A. Kam
neva\, PharmD\, BCPS\, RPh\, and Lindsay Goolsby\, MS\, R
D\, LDN\, CDCES\, discuss nonpharmacologic therapies for Heart Fa
ilure (HF). In particular\, they review the importance of dietary manageme
nt\, weight control\, diabetes management\, and participation in cardiac r
ehabilitation.
\n\n
This webinar is part of the
Transform HF Care: New Horizons in Treatment initiative
\, supported by Bayer AG. Visit the
Managing HF Acro
ss the Spectrum: From Recognizing Symptoms to Implementing Appropriate Tre
atment online course to access additional educational activit
ies on this topic.
\n\n
Key Objectives/Learni
ng Outcomes:
\n
\n- Evaluate the epidemio
logy\, risk factors\, comorbidities\, and community aspects associated wit
h HF to determine best practices for care.
\n- Distinguish pathophy
siologic characteristics when evaluating and diagnosing HF\, including cur
rent classifications\, genotypes\, and phenotypes\, to analyze best HF ris
k stratification\, prevention\, and management strategies.
\n- Inco
rporate GDMT\, newer therapies\, and interprofessional team strategies int
o treatment care plans for the management of HF to improve care coordinati
on\, communication\, and patient outcomes.
\n
\n\n
Webinar Recording
\n
\n\n
\n\n
Webinar
Participants
\n
Oksana A. Kamneva\, PharmD\,
BCPS\, RPh
\nLindsay Goolsby\, MS\, RD\, LDN\, CDCES
\n\n
Credit Information
\n
No credit is bein
g offered for this webinar.
\n\n